Masimo delivered Q3 results that mostly aligned with guidance, yet it faces challenges in its non-healthcare segment.

Executives said the patient monitoring company’s consumer business will likely become a discontinued operation if it is not ...

These are independent reviews of the products mentioned ... and pulse rate tracking: the Masimo W1 Medical watch. “If you really want a wearable that’s going to help you manage your health ...

Masimo (Nasdaq:MASI) shares ticked up before hours today on third-quarter results that came in ahead of the consensus ...

Needham analyst Michael Matson maintained a Hold rating on Masimo (MASI – Research Report) today. The company’s shares closed ...

This means that Apple has enough money to buy five iPhone 16 cases, but Masimo can continue to sell its products. Apple attorney John Desmarais told Bloomberg Law, “We’re not here for the ...

markets sells and licenses premium and luxury audio sound products and related integration technologies. Understanding the Numbers: Masimo's Finances Market Capitalization Analysis: The company's ...

The $250 (yep, there’s no missing ‘M’ from the end of that number) Apple was awarded in its patent infringement case against Masimo might seem amusing – as John Gruber wryly noted ...

Masimo Corp. ( (MASI) ) has released its Q3 earnings. Here is a breakdown of the information Masimo Corp. presented to its investors. Masimo ...

Masimo MASI2.20%increase; green up pointing triangle said Joe Kiani, who previously informed the board of his decision to resign as chief executive, has been terminated by the company. Kiani’s ...

Apple and Masimo's patent and trade secret dispute has intensified through lawsuits as Apple defends its innovations and Masimo's claims are rejected in court. Apple and medical equipment maker ...

Masimo MASI is set to give its latest quarterly ... remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures ...